Table 6.
Imaging findings and clinical treatment of MDR spinal TB
| Characteristic | N (%) |
|---|---|
| Site | 272 (100) |
| Cervical | 16 (5.88) |
| Cervicothoracic | 5 (1.84) |
| Thoracic | 97 (35.66) |
| Thoracolumbar | 43 (15.81) |
| Lumbar | 85 (31.25) |
| Lumbosacral | 26 (9.56) |
| Number of vertebrae involved | 272 (100) |
| 1–2 | 199 (73.16) |
| 3–4 | 54 (19.85) |
| ⩾5 | 19 (6.99) |
| Treatment | 272 (100) |
| Only Chemotherapy | 106 (38.97) |
| Chemotherapy + Local CT guided puncture | 7 (2.57) |
| Chemotherapy + Operation | 159 (58.46) |
| Drug-related complications | 21 (7.72) |
| Gastrointestinal symptoms | 13 (4.78) |
| Liver injury | 6 (2.21) |
| Peripheral nerve damage | 1 (0.37) |
| Hearing impairment | 1 (0.37) |
| Postoperative complications | 39 (24.53) |
| Sinus formation | 17 (10.69) |
| Delayed paralysis | 5 (3.14) |
| Incision disunion | 11 (6.92) |
| Instrumentation fracture | 2 (1.26) |
| Recurrence | 14 (8.81) |
| Local abscesses | 9 (5.66) |
| New abscesses at the non-surgical section | 5 (3.14) |
MDR: multi-drug resistant; TB: tuberculosis.
CT: computed tomography.